| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06:18 | U.S. Senate votes to back Trump on Iran strikes | ||
| 06:18 | Australia's trade surplus shrinks to AUD 2.63B in January, missing forecasts as export momentum fades | ||
| 06:12 | MicroVision outlines $10M-$15M 2026 revenue target amid LiDAR 2.0 transformation and expanded defense push | ||
| 06:06 | Thursday's Economic Calendar | ||
| 06:00 | Elon Musk says he paid full price for Twitter due to 'biased' Delaware judge | ||
| 05:54 | Viemed Healthcare reports mixed Q4 results; introduces FY26 outlook | ||
| 05:36 | Stevanato Group outlines 2026 revenue target up to €1.308B with high-value solutions set to reach 48% of sales | ||
| 05:30 | Vermilion Energy raises dividend by 4% to C$0.135 | ||
| 05:30 | Goldman Sachs CEO David Solomon watching for 'frothiness' in private credit market | ||
| 05:24 | Baytex Energy declares CAD 0.0225 dividend | ||
| 05:12 | Anthropic CEO Dario Amodei back in talks with Pentagon about AI deal, FT reports | ||
| 04:36 | Broadcom forecasts AI chip revenue surpassing $100B in 2027 as AI demand accelerates | ||
| 04:30 | Veeva signals CRM to comprise 10% of revenue by 2030 as AI momentum builds | ||
| 04:06 | Okta outlines 9% revenue growth target for FY 2027 as AI agent security drives new product momentum | ||
| 03:24 | TriplePoint Venture Growth outlines $25M-$50M quarterly fundings target amid AI portfolio shift in 2026 | ||
| 03:24 | Magnachip outlines 2026 product launches with new generation products to comprise 10% of revenue | ||
| 02:06 | Alto Ingredients outlines $15M 45Z tax credit target for 2026 amid expanded CO2 operations and cost reductions | ||
| 01:54 | Surging U.S. diesel futures indicate energy bull move far from over, analyst says | ||
| 01:24 | U.S. expands Latin America drug fight with joint operation in Ecuador | ||
| 01:18 | Niagen Bioscience targets 10-15% revenue growth for 2026 while expanding injectable product line | ||
| 01:12 | Sight Sciences outlines $82M-$88M 2026 revenue target while expanding interventional dry eye strategy | ||
| 01:12 | Smith Micro outlines leadership transition and targets Q2 2026 non-GAAP profitability amid strong SafePath OS momentum | ||
| 00:48 | Baytex Energy President/COO Lundberg to succeed Greager as CEO | ||
| 00:36 | Verastem outlines 2026 milestones with CO-PACK franchise set to be self-sustaining in H2 | ||
| 00:36 | Baytex Energy GAAP EPS of -C$1.12, revenue of C$759.82M |